相关实验视频

Updated: Jun 3, 2025

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

中等风险的乳头类甲状腺癌的治疗策略:专注于手术后的甲状腺功能低下症后的叶片切除术

Akifumi Kariya¹, Tomoyasu Tachibana², Asuka Sato²

¹Department of Otolaryngology Head and Neck Surgery, Japanese Red Cross Society Himeji Hospital, 12-1 Shimoteno 1-Chome, Himeji, Hyogo 670-8540, Japan; Department of Otolaryngology Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama 700-8558, Japan.

Auris, nasus, larynx

|January 12, 2025

概括

对于中等风险的乳头甲状腺癌,全甲状腺切除术和叶片切除术显示出相似的生存率和复发率. 在TSH水平较高的患者中,全甲状腺切除术可能是首选的,以避免手术后的甲状腺功能低下.

科学领域:

内分泌学在内分泌学.
手术瘤学手术瘤学
甲状腺癌研究研究

背景情况:

对于中等风险的乳头甲状腺癌 (PTC) 的最佳手术策略仍在争论中.
手术决策应该平衡治疗疗效与术后并发症.

研究的目的:

为了比较整个甲状腺切除术的治疗结果和并发症与中等风险PTC的带切除术.
根据患者特定的因素,确定适当的外科手术策略.

主要方法:

对123名中等风险PTC患者 (2008年1月至2022年12月) 的回顾性分析.
基于2024年日本内分泌外科协会指南的PTC风险分类.
整体甲状腺切除术 (n=27) 和分叶切除术 (n=96) 组之间的结果比较.

主要成果:

手术组之间生存率或复发率没有显著差异.
单边复发性喉神经麻发生在5.2% (全甲状腺切除术) 和18.5% (腹腔切除术) (p=0.04) 的患者中.
在甲状腺切除术总病例的7.4%中出现永久性甲状腺缺血症;在43.8%的带切除术病例中出现术后的甲状腺功能低下症,与手术前的TSH≥2.0μIU/mL (p<0.001) 相关.

结论:

整体甲状腺切除术和带切除术为中等风险的PTC提供了可比的瘤结果.
对于手术前TSH≥2.0μIU/mL的患者,全甲状腺切除可能是有利的,因为手术后甲状腺功能低下的风险降低了.

关键词:

中级风险的乳头甲状腺癌输卵管切除术 (lobectomy) 是一个切除术.手术后的甲状腺功能低下症整体甲状腺切除术是什么

更多相关视频

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

相关概念视频

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...